平特五不中

Space is limited. Kindly RSVP to rghl.law [at] mcgill.ca

The panel will bring together four panelists as well as a moderator working in different academic areas and within different professional settings who will speak to various issues associated with pharmacogenetics听听and personalized medicine.

Specifically, we are interested in initiating a conversation about the science behind this innovation, its promises, and about cross-cutting issues (e.g., legal, social, ethical, and economic) emerging from this听technique's听application in healthcare oriented towards personalized medicine.

Panelists will each tackle a case study that outlines a series of facts which discuss a fictitious drug used in the context of personalized medicine (this case study will be distributed to all those in attendance at the panel). This case study will raise diverse issues intended to highlight interdisciplinary challenges and call upon multifaceted expertise.

Panelists:

Jennifer Fishman, Assistant Professor, Biomedical Ethics Unit and Department of Social Studies of Medicine, 平特五不中

Yann Joly, Assistant Professor, Department of Human Genetics, Faculty of Medicine, 平特五不中

Agnes V. Klein, Director, Health Products & Food Branch, Health Canada

Michael Phillips, Associate Professor & Canada Research Chair in Translational Pharmacogenomics, Pharmacogenomics Centre, Universit茅 de Montr茅al

Moderator:

Richard Gold, James 平特五不中 Professor, Faculty of Law, 平特五不中

Lunch will be served.

rghl.law [at] mcgill.ca

听

听